APO Research
Talk to an analyst

APO RESEARCH · REPORT

Amplicon Sequencing

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Amplicon Sequencing Market Analysis and Forecast 2026-2032

4 March 2026217 pages

Choose your research edition.

Industry ResearchAmplicon Sequencing Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Amplicon Sequencing Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Amplicon Sequencing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Amplicon Sequencing Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Amplicon Sequencing Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Amplicon Sequencing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Amplicon Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Amplicon Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Amplicon Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Amplicon Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Amplicon Sequencing include IDT, Azenta Life Sciences, Eurofins Genomics, Novogene, BGI (BGI Genomics), Macrogen, Psomagen, SeqMatic and CD Genomics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Amplicon Sequencing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Amplicon Sequencing, also provides the revenue of main regions and countries. Of the upcoming market potential for Amplicon Sequencing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Amplicon Sequencing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Amplicon Sequencing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Amplicon Sequencing revenue, projected growth trends, production technology, application and end-user industry.

Amplicon Sequencing Segment by Company

IDT

Azenta Life Sciences

Eurofins Genomics

Novogene

BGI (BGI Genomics)

Macrogen

Psomagen

SeqMatic

CD Genomics

AllGenetics

Charles River

Source BioScience

AGRF

Plasmidsaurus

Eurofins Scientific

Charles River Laboratories

ABM

Zymo Research

Paragon Genomics

Quintara Bio

HyLabs

MUGTC

SeqCoast Genomics

Shanghai Baiqu Biomedical Technology

Illumina

Guangzhou IGE Biotechnology

Amplicon Sequencing Segment by Type

16S rDNA Sequencing

ITS Sequencing

Target Region Amplicon Sequencing

Others

Amplicon Sequencing Segment by Application

Human Health and Clinical Research

Agriculture and Food Safety

Pharmaceutical and Biotechnology Research

Forensics and Population Genetics

Others

Amplicon Sequencing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amplicon Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Amplicon Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amplicon Sequencing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Amplicon Sequencing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Amplicon Sequencing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Amplicon Sequencing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Amplicon Sequencing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 16S rDNA Sequencing Major Player Table 3. ITS Sequencing Major Player Table 4. Target Region Amplicon Sequencing Major Player Table 5. Others Major Player Table 6. Global Amplicon Sequencing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Human Health and Clinical Research Major Player Table 8. Agriculture and Food Safety Major Player Table 9. Pharmaceutical and Biotechnology Research Major Player Table 10. Forensics and Population Genetics Major Player Table 11. Others Major Player Table 12. Amplicon Sequencing Industry Trends Table 13. Amplicon Sequencing Industry Drivers Table 14. Amplicon Sequencing Industry Opportunities and Challenges Table 15. Amplicon Sequencing Industry Restraints Table 16. Global Amplicon Sequencing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Amplicon Sequencing Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Amplicon Sequencing Market Share by Region (2021-2026) Table 19. Global Amplicon Sequencing Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Amplicon Sequencing Market Share by Region (2027-2032) Table 21. Global Amplicon Sequencing Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Amplicon Sequencing Revenue Market Share by Players (2021-2026) Table 23. Global Amplicon Sequencing Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Amplicon Sequencing Key Players Headquarters & Area Served Table 25. Global Amplicon Sequencing Players, Product Type & Application Table 26. Global Amplicon Sequencing Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Amplicon Sequencing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Amplicon Sequencing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Amplicon Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Amplicon Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Amplicon Sequencing Revenue Market Share by Type (2021-2026) Table 33. Global Amplicon Sequencing Revenue Market Share by Type (2027-2032) Table 34. Global Amplicon Sequencing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Amplicon Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Amplicon Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Amplicon Sequencing Revenue Market Share by Application (2021-2026) Table 38. Global Amplicon Sequencing Revenue Market Share by Application (2027-2032) Table 39. IDT Company Information Table 40. IDT Business Overview Table 41. IDT Amplicon Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. IDT Amplicon Sequencing Product Portfolio Table 43. IDT Recent Development Table 44. Azenta Life Sciences Company Information Table 45. Azenta Life Sciences Business Overview Table 46. Azenta Life Sciences Amplicon Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Azenta Life Sciences Amplicon Sequencing Product Portfolio Table 48. Azenta Life Sciences Recent Development Table 49. Eurofins Genomics Company Information Table 50. Eurofins Genomics Business Overview Table 51. Eurofins Genomics Amplicon Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Eurofins Genomics Amplicon Sequencing Product Portfolio Table 53. Eurofins Genomics Recent Development Table 54. Novogene Company Information Table 55. Novogene Business Overview Table 56. Novogene Amplicon Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Novogene Amplicon Sequencing Product Portfolio Table 58. Novogene Recent Development Table 59. BGI (BGI Genomics) Company Information Table 60. BGI (BGI Genomics) Business Overview Table 61. BGI (BGI Genomics) Amplicon Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. BGI (BGI Genomics) Amplicon Sequencing Product Portfolio Table 63. BGI (BGI Genomics) Recent Development Table 64. Macrogen Company Information Table 65. Macrogen Business Overview Table 66. Macrogen Amplicon Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Macrogen Amplicon Sequencing Product Portfolio Table 68. Macrogen Recent Development Table 69. Psomagen Company Information Table 70. Psomagen Business Overview Table 71. Psomagen Amplicon Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Psomagen Amplicon Sequencing Product Portfolio Table 73. Psomagen Recent Development Table 74. SeqMatic Company Information Table 75. SeqMatic Business Overview Table 76. SeqMatic Amplicon Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. SeqMatic Amplicon Sequencing Product Portfolio Table 78. SeqMatic Recent Development Table 79. CD Genomics Company Information Table 80. CD Genomics Business Overview Table 81. CD Genomics Amplicon Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. CD Genomics Amplicon Sequencing Product Portfolio Table 83. CD Genomics Recent Development Table 84. AllGenetics Company Information Table 85. AllGenetics Business Overview Table 86. AllGenetics Amplicon Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. AllGenetics Amplicon Sequencing Product Portfolio Table 88. AllGenetics Recent Development Table 89. Charles River Company Information Table 90. Charles River Business Overview Table 91. Charles River Amplicon Sequencing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Charles River Amplicon Sequencing Product Portfolio Table 93. Charles River Recent Development Table 94. Source BioScience Company Information Table 95. Source BioScience Business Overview Table 96. Source BioScience Amplicon Sequencing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Source BioScience Amplicon Sequencing Product Portfolio Table 98. Source BioScience Recent Development Table 99. AGRF Company Information Table 100. AGRF Business Overview Table 101. AGRF Amplicon Sequencing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. AGRF Amplicon Sequencing Product Portfolio Table 103. AGRF Recent Development Table 104. Plasmidsaurus Company Information Table 105. Plasmidsaurus Business Overview Table 106. Plasmidsaurus Amplicon Sequencing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Plasmidsaurus Amplicon Sequencing Product Portfolio Table 108. Plasmidsaurus Recent Development Table 109. Eurofins Scientific Company Information Table 110. Eurofins Scientific Business Overview Table 111. Eurofins Scientific Amplicon Sequencing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Eurofins Scientific Amplicon Sequencing Product Portfolio Table 113. Eurofins Scientific Recent Development Table 114. Charles River Laboratories Company Information Table 115. Charles River Laboratories Business Overview Table 116. Charles River Laboratories Amplicon Sequencing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Charles River Laboratories Amplicon Sequencing Product Portfolio Table 118. Charles River Laboratories Recent Development Table 119. ABM Company Information Table 120. ABM Business Overview Table 121. ABM Amplicon Sequencing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. ABM Amplicon Sequencing Product Portfolio Table 123. ABM Recent Development Table 124. Zymo Research Company Information Table 125. Zymo Research Business Overview Table 126. Zymo Research Amplicon Sequencing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. Zymo Research Amplicon Sequencing Product Portfolio Table 128. Zymo Research Recent Development Table 129. Paragon Genomics Company Information Table 130. Paragon Genomics Business Overview Table 131. Paragon Genomics Amplicon Sequencing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. Paragon Genomics Amplicon Sequencing Product Portfolio Table 133. Paragon Genomics Recent Development Table 134. Quintara Bio Company Information Table 135. Quintara Bio Business Overview Table 136. Quintara Bio Amplicon Sequencing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 137. Quintara Bio Amplicon Sequencing Product Portfolio Table 138. Quintara Bio Recent Development Table 139. HyLabs Company Information Table 140. HyLabs Business Overview Table 141. HyLabs Amplicon Sequencing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 142. HyLabs Amplicon Sequencing Product Portfolio Table 143. HyLabs Recent Development Table 144. MUGTC Company Information Table 145. MUGTC Business Overview Table 146. MUGTC Amplicon Sequencing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 147. MUGTC Amplicon Sequencing Product Portfolio Table 148. MUGTC Recent Development Table 149. SeqCoast Genomics Company Information Table 150. SeqCoast Genomics Business Overview Table 151. SeqCoast Genomics Amplicon Sequencing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 152. SeqCoast Genomics Amplicon Sequencing Product Portfolio Table 153. SeqCoast Genomics Recent Development Table 154. Shanghai Baiqu Biomedical Technology Company Information Table 155. Shanghai Baiqu Biomedical Technology Business Overview Table 156. Shanghai Baiqu Biomedical Technology Amplicon Sequencing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 157. Shanghai Baiqu Biomedical Technology Amplicon Sequencing Product Portfolio Table 158. Shanghai Baiqu Biomedical Technology Recent Development Table 159. Illumina Company Information Table 160. Illumina Business Overview Table 161. Illumina Amplicon Sequencing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 162. Illumina Amplicon Sequencing Product Portfolio Table 163. Illumina Recent Development Table 164. Guangzhou IGE Biotechnology Company Information Table 165. Guangzhou IGE Biotechnology Business Overview Table 166. Guangzhou IGE Biotechnology Amplicon Sequencing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 167. Guangzhou IGE Biotechnology Amplicon Sequencing Product Portfolio Table 168. Guangzhou IGE Biotechnology Recent Development Table 169. North America Amplicon Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 170. North America Amplicon Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 171. North America Amplicon Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 172. North America Amplicon Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 173. North America Amplicon Sequencing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. North America Amplicon Sequencing Revenue by Country (2021-2026) & (US$ Million) Table 175. North America Amplicon Sequencing Revenue by Country (US$ Million) & (2027-2032) Table 176. Europe Amplicon Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 177. Europe Amplicon Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 178. Europe Amplicon Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 179. Europe Amplicon Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 180. Europe Amplicon Sequencing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. Europe Amplicon Sequencing Revenue by Country (2021-2026) & (US$ Million) Table 182. Europe Amplicon Sequencing Revenue by Country (US$ Million) & (2027-2032) Table 183. China Amplicon Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 184. China Amplicon Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 185. China Amplicon Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 186. China Amplicon Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 187. Asia Amplicon Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 188. Asia Amplicon Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 189. Asia Amplicon Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 190. Asia Amplicon Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 191. Asia Amplicon Sequencing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 192. Asia Amplicon Sequencing Revenue by Region (US$ Million) & (2021-2026) Table 193. Asia Amplicon Sequencing Revenue by Region (US$ Million) & (2027-2032) Table 194. SAMEA Amplicon Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 195. SAMEA Amplicon Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 196. SAMEA Amplicon Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 197. SAMEA Amplicon Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 198. SAMEA Amplicon Sequencing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 199. SAMEA Amplicon Sequencing Revenue by Country (2021-2026) & (US$ Million) Table 200. SAMEA Amplicon Sequencing Revenue by Country (US$ Million) & (2027-2032) Table 201. Research Programs/Design for This Report Table 202. Authors List of This Report Table 203. Secondary Sources Table 204. Primary Sources List of Figures Figure 1. Amplicon Sequencing Image Figure 2. Global Amplicon Sequencing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Amplicon Sequencing Market Size Share 2021 VS 2025 VS 2032 Figure 4. 16S rDNA Sequencing Image Figure 5. ITS Sequencing Image Figure 6. Target Region Amplicon Sequencing Image Figure 7. Others Image Figure 8. Global Amplicon Sequencing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Amplicon Sequencing Market Size Share 2021 VS 2025 VS 2032 Figure 10. Human Health and Clinical Research Image Figure 11. Agriculture and Food Safety Image Figure 12. Pharmaceutical and Biotechnology Research Image Figure 13. Forensics and Population Genetics Image Figure 14. Others Image Figure 15. Global Amplicon Sequencing Market Size (US$ Million) & (2021-2032) Figure 16. Global Amplicon Sequencing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Amplicon Sequencing Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Amplicon Sequencing Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Amplicon Sequencing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Amplicon Sequencing Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Amplicon Sequencing Revenue Market Share by Type (2021-2032) Figure 23. Global Amplicon Sequencing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Amplicon Sequencing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Amplicon Sequencing Revenue Market Share by Application (2021-2032) Figure 26. North America Amplicon Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Amplicon Sequencing Revenue Share by Type (2021-2032) Figure 28. North America Amplicon Sequencing Revenue Share by Application (2021-2032) Figure 29. North America Amplicon Sequencing Revenue Share by Country (2021-2032) Figure 30. United States Amplicon Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Amplicon Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Amplicon Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Amplicon Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Amplicon Sequencing Revenue Share by Type (2021-2032) Figure 35. Europe Amplicon Sequencing Revenue Share by Application (2021-2032) Figure 36. Europe Amplicon Sequencing Revenue Share by Country (2021-2032) Figure 37. Germany Amplicon Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Amplicon Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Amplicon Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Amplicon Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Amplicon Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Amplicon Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Amplicon Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Amplicon Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Amplicon Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Amplicon Sequencing Revenue Share by Type (2021-2032) Figure 47. China Amplicon Sequencing Revenue Share by Application (2021-2032) Figure 48. Asia Amplicon Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Amplicon Sequencing Revenue Share by Type (2021-2032) Figure 50. Asia Amplicon Sequencing Revenue Share by Application (2021-2032) Figure 51. Asia Amplicon Sequencing Revenue Share by Region (2021-2032) Figure 52. Japan Amplicon Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Amplicon Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Amplicon Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Amplicon Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Amplicon Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Amplicon Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Amplicon Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Amplicon Sequencing Revenue Share by Type (2021-2032) Figure 60. SAMEA Amplicon Sequencing Revenue Share by Application (2021-2032) Figure 61. SAMEA Amplicon Sequencing Revenue Share by Country (2021-2032) Figure 62. Brazil Amplicon Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Amplicon Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Amplicon Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Amplicon Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Amplicon Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Amplicon Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Amplicon Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Amplicon Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Amplicon Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Amplicon Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Amplicon Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 16S rDNA Sequencing
  • ITS Sequencing
  • Target Region Amplicon Sequencing
  • Others
Applications
  • Human Health and Clinical Research
  • Agriculture and Food Safety
  • Pharmaceutical and Biotechnology Research
  • Forensics and Population Genetics
  • Others
Companies covered
  • IDT
  • Azenta Life Sciences
  • Eurofins Genomics
  • Novogene
  • BGI (BGI Genomics)
  • Macrogen
  • Psomagen
  • SeqMatic
  • CD Genomics
  • AllGenetics
  • Charles River
  • Source BioScience
  • AGRF
  • Plasmidsaurus
  • Eurofins Scientific
  • Charles River Laboratories
  • ABM
  • Zymo Research
  • Paragon Genomics
  • Quintara Bio
  • HyLabs
  • MUGTC
  • SeqCoast Genomics
  • Shanghai Baiqu Biomedical Technology
  • Illumina
  • Guangzhou IGE Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Amplicon Sequencing Market by Type
  3. 1.2.1 Global Amplicon Sequencing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 16S rDNA Sequencing
  5. 1.2.3 ITS Sequencing
  6. 1.2.4 Target Region Amplicon Sequencing
  7. 1.2.5 Others
  8. 1.3 Amplicon Sequencing Market by Application
  9. 1.3.1 Global Amplicon Sequencing Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Human Health and Clinical Research
  11. 1.3.3 Agriculture and Food Safety
  12. 1.3.4 Pharmaceutical and Biotechnology Research
  13. 1.3.5 Forensics and Population Genetics
  14. 1.3.6 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Amplicon Sequencing Market Dynamics
  1. 2.1 Amplicon Sequencing Industry Trends
  2. 2.2 Amplicon Sequencing Industry Drivers
  3. 2.3 Amplicon Sequencing Industry Opportunities and Challenges
  4. 2.4 Amplicon Sequencing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Amplicon Sequencing Market Perspective (2021-2032)
  2. 3.2 Global Amplicon Sequencing Growth Trends by Region
  3. 3.2.1 Global Amplicon Sequencing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Amplicon Sequencing Market Size by Region (2021-2026)
  5. 3.2.3 Global Amplicon Sequencing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Amplicon Sequencing Revenue by Players
  2. 4.1.1 Global Amplicon Sequencing Revenue by Players (2021-2026)
  3. 4.1.2 Global Amplicon Sequencing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Amplicon Sequencing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Amplicon Sequencing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Amplicon Sequencing Key Players Headquarters & Area Served
  7. 4.4 Global Amplicon Sequencing Players, Product Type & Application
  8. 4.5 Global Amplicon Sequencing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Amplicon Sequencing Market CR5 and HHI
  11. 4.6.3 2025 Amplicon Sequencing Tier 1, Tier 2, and Tier 3
5 Amplicon Sequencing Market Size by Type
  1. 5.1 Global Amplicon Sequencing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Amplicon Sequencing Revenue by Type (2021-2032)
  3. 5.3 Global Amplicon Sequencing Revenue Market Share by Type (2021-2032)
6 Amplicon Sequencing Market Size by Application
  1. 6.1 Global Amplicon Sequencing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Amplicon Sequencing Revenue by Application (2021-2032)
  3. 6.3 Global Amplicon Sequencing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 IDT
  2. 7.1.1 IDT Company Information
  3. 7.1.2 IDT Business Overview
  4. 7.1.3 IDT Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 IDT Amplicon Sequencing Product Portfolio
  6. 7.1.5 IDT Recent Developments
  7. 7.2 Azenta Life Sciences
  8. 7.2.1 Azenta Life Sciences Company Information
  9. 7.2.2 Azenta Life Sciences Business Overview
  10. 7.2.3 Azenta Life Sciences Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Azenta Life Sciences Amplicon Sequencing Product Portfolio
  12. 7.2.5 Azenta Life Sciences Recent Developments
  13. 7.3 Eurofins Genomics
  14. 7.3.1 Eurofins Genomics Company Information
  15. 7.3.2 Eurofins Genomics Business Overview
  16. 7.3.3 Eurofins Genomics Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Eurofins Genomics Amplicon Sequencing Product Portfolio
  18. 7.3.5 Eurofins Genomics Recent Developments
  19. 7.4 Novogene
  20. 7.4.1 Novogene Company Information
  21. 7.4.2 Novogene Business Overview
  22. 7.4.3 Novogene Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Novogene Amplicon Sequencing Product Portfolio
  24. 7.4.5 Novogene Recent Developments
  25. 7.5 BGI (BGI Genomics)
  26. 7.5.1 BGI (BGI Genomics) Company Information
  27. 7.5.2 BGI (BGI Genomics) Business Overview
  28. 7.5.3 BGI (BGI Genomics) Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 BGI (BGI Genomics) Amplicon Sequencing Product Portfolio
  30. 7.5.5 BGI (BGI Genomics) Recent Developments
  31. 7.6 Macrogen
  32. 7.6.1 Macrogen Company Information
  33. 7.6.2 Macrogen Business Overview
  34. 7.6.3 Macrogen Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Macrogen Amplicon Sequencing Product Portfolio
  36. 7.6.5 Macrogen Recent Developments
  37. 7.7 Psomagen
  38. 7.7.1 Psomagen Company Information
  39. 7.7.2 Psomagen Business Overview
  40. 7.7.3 Psomagen Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Psomagen Amplicon Sequencing Product Portfolio
  42. 7.7.5 Psomagen Recent Developments
  43. 7.8 SeqMatic
  44. 7.8.1 SeqMatic Company Information
  45. 7.8.2 SeqMatic Business Overview
  46. 7.8.3 SeqMatic Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 SeqMatic Amplicon Sequencing Product Portfolio
  48. 7.8.5 SeqMatic Recent Developments
  49. 7.9 CD Genomics
  50. 7.9.1 CD Genomics Company Information
  51. 7.9.2 CD Genomics Business Overview
  52. 7.9.3 CD Genomics Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 CD Genomics Amplicon Sequencing Product Portfolio
  54. 7.9.5 CD Genomics Recent Developments
  55. 7.10 AllGenetics
  56. 7.10.1 AllGenetics Company Information
  57. 7.10.2 AllGenetics Business Overview
  58. 7.10.3 AllGenetics Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 AllGenetics Amplicon Sequencing Product Portfolio
  60. 7.10.5 AllGenetics Recent Developments
  61. 7.11 Charles River
  62. 7.11.1 Charles River Company Information
  63. 7.11.2 Charles River Business Overview
  64. 7.11.3 Charles River Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Charles River Amplicon Sequencing Product Portfolio
  66. 7.11.5 Charles River Recent Developments
  67. 7.12 Source BioScience
  68. 7.12.1 Source BioScience Company Information
  69. 7.12.2 Source BioScience Business Overview
  70. 7.12.3 Source BioScience Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Source BioScience Amplicon Sequencing Product Portfolio
  72. 7.12.5 Source BioScience Recent Developments
  73. 7.13 AGRF
  74. 7.13.1 AGRF Company Information
  75. 7.13.2 AGRF Business Overview
  76. 7.13.3 AGRF Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  77. 7.13.4 AGRF Amplicon Sequencing Product Portfolio
  78. 7.13.5 AGRF Recent Developments
  79. 7.14 Plasmidsaurus
  80. 7.14.1 Plasmidsaurus Company Information
  81. 7.14.2 Plasmidsaurus Business Overview
  82. 7.14.3 Plasmidsaurus Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Plasmidsaurus Amplicon Sequencing Product Portfolio
  84. 7.14.5 Plasmidsaurus Recent Developments
  85. 7.15 Eurofins Scientific
  86. 7.15.1 Eurofins Scientific Company Information
  87. 7.15.2 Eurofins Scientific Business Overview
  88. 7.15.3 Eurofins Scientific Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Eurofins Scientific Amplicon Sequencing Product Portfolio
  90. 7.15.5 Eurofins Scientific Recent Developments
  91. 7.16 Charles River Laboratories
  92. 7.16.1 Charles River Laboratories Company Information
  93. 7.16.2 Charles River Laboratories Business Overview
  94. 7.16.3 Charles River Laboratories Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Charles River Laboratories Amplicon Sequencing Product Portfolio
  96. 7.16.5 Charles River Laboratories Recent Developments
  97. 7.17 ABM
  98. 7.17.1 ABM Company Information
  99. 7.17.2 ABM Business Overview
  100. 7.17.3 ABM Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  101. 7.17.4 ABM Amplicon Sequencing Product Portfolio
  102. 7.17.5 ABM Recent Developments
  103. 7.18 Zymo Research
  104. 7.18.1 Zymo Research Company Information
  105. 7.18.2 Zymo Research Business Overview
  106. 7.18.3 Zymo Research Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Zymo Research Amplicon Sequencing Product Portfolio
  108. 7.18.5 Zymo Research Recent Developments
  109. 7.19 Paragon Genomics
  110. 7.19.1 Paragon Genomics Company Information
  111. 7.19.2 Paragon Genomics Business Overview
  112. 7.19.3 Paragon Genomics Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Paragon Genomics Amplicon Sequencing Product Portfolio
  114. 7.19.5 Paragon Genomics Recent Developments
  115. 7.20 Quintara Bio
  116. 7.20.1 Quintara Bio Company Information
  117. 7.20.2 Quintara Bio Business Overview
  118. 7.20.3 Quintara Bio Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Quintara Bio Amplicon Sequencing Product Portfolio
  120. 7.20.5 Quintara Bio Recent Developments
  121. 7.21 HyLabs
  122. 7.21.1 HyLabs Company Information
  123. 7.21.2 HyLabs Business Overview
  124. 7.21.3 HyLabs Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  125. 7.21.4 HyLabs Amplicon Sequencing Product Portfolio
  126. 7.21.5 HyLabs Recent Developments
  127. 7.22 MUGTC
  128. 7.22.1 MUGTC Company Information
  129. 7.22.2 MUGTC Business Overview
  130. 7.22.3 MUGTC Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  131. 7.22.4 MUGTC Amplicon Sequencing Product Portfolio
  132. 7.22.5 MUGTC Recent Developments
  133. 7.23 SeqCoast Genomics
  134. 7.23.1 SeqCoast Genomics Company Information
  135. 7.23.2 SeqCoast Genomics Business Overview
  136. 7.23.3 SeqCoast Genomics Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  137. 7.23.4 SeqCoast Genomics Amplicon Sequencing Product Portfolio
  138. 7.23.5 SeqCoast Genomics Recent Developments
  139. 7.24 Shanghai Baiqu Biomedical Technology
  140. 7.24.1 Shanghai Baiqu Biomedical Technology Company Information
  141. 7.24.2 Shanghai Baiqu Biomedical Technology Business Overview
  142. 7.24.3 Shanghai Baiqu Biomedical Technology Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  143. 7.24.4 Shanghai Baiqu Biomedical Technology Amplicon Sequencing Product Portfolio
  144. 7.24.5 Shanghai Baiqu Biomedical Technology Recent Developments
  145. 7.25 Illumina
  146. 7.25.1 Illumina Company Information
  147. 7.25.2 Illumina Business Overview
  148. 7.25.3 Illumina Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  149. 7.25.4 Illumina Amplicon Sequencing Product Portfolio
  150. 7.25.5 Illumina Recent Developments
  151. 7.26 Guangzhou IGE Biotechnology
  152. 7.26.1 Guangzhou IGE Biotechnology Company Information
  153. 7.26.2 Guangzhou IGE Biotechnology Business Overview
  154. 7.26.3 Guangzhou IGE Biotechnology Amplicon Sequencing Revenue and Gross Margin (2021-2026)
  155. 7.26.4 Guangzhou IGE Biotechnology Amplicon Sequencing Product Portfolio
  156. 7.26.5 Guangzhou IGE Biotechnology Recent Developments
8 North America
  1. 8.1 North America Amplicon Sequencing Revenue (2021-2032)
  2. 8.2 North America Amplicon Sequencing Revenue by Type (2021-2032)
  3. 8.2.1 North America Amplicon Sequencing Revenue by Type (2021-2026)
  4. 8.2.2 North America Amplicon Sequencing Revenue by Type (2027-2032)
  5. 8.3 North America Amplicon Sequencing Revenue Share by Type (2021-2032)
  6. 8.4 North America Amplicon Sequencing Revenue by Application (2021-2032)
  7. 8.4.1 North America Amplicon Sequencing Revenue by Application (2021-2026)
  8. 8.4.2 North America Amplicon Sequencing Revenue by Application (2027-2032)
  9. 8.5 North America Amplicon Sequencing Revenue Share by Application (2021-2032)
  10. 8.6 North America Amplicon Sequencing Revenue by Country
  11. 8.6.1 North America Amplicon Sequencing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Amplicon Sequencing Revenue by Country (2021-2026)
  13. 8.6.3 North America Amplicon Sequencing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Amplicon Sequencing Revenue (2021-2032)
  2. 9.2 Europe Amplicon Sequencing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Amplicon Sequencing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Amplicon Sequencing Revenue by Type (2027-2032)
  5. 9.3 Europe Amplicon Sequencing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Amplicon Sequencing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Amplicon Sequencing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Amplicon Sequencing Revenue by Application (2027-2032)
  9. 9.5 Europe Amplicon Sequencing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Amplicon Sequencing Revenue by Country
  11. 9.6.1 Europe Amplicon Sequencing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Amplicon Sequencing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Amplicon Sequencing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Amplicon Sequencing Revenue (2021-2032)
  2. 10.2 China Amplicon Sequencing Revenue by Type (2021-2032)
  3. 10.2.1 China Amplicon Sequencing Revenue by Type (2021-2026)
  4. 10.2.2 China Amplicon Sequencing Revenue by Type (2027-2032)
  5. 10.3 China Amplicon Sequencing Revenue Share by Type (2021-2032)
  6. 10.4 China Amplicon Sequencing Revenue by Application (2021-2032)
  7. 10.4.1 China Amplicon Sequencing Revenue by Application (2021-2026)
  8. 10.4.2 China Amplicon Sequencing Revenue by Application (2027-2032)
  9. 10.5 China Amplicon Sequencing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Amplicon Sequencing Revenue (2021-2032)
  2. 11.2 Asia Amplicon Sequencing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Amplicon Sequencing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Amplicon Sequencing Revenue by Type (2027-2032)
  5. 11.3 Asia Amplicon Sequencing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Amplicon Sequencing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Amplicon Sequencing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Amplicon Sequencing Revenue by Application (2027-2032)
  9. 11.5 Asia Amplicon Sequencing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Amplicon Sequencing Revenue by Country
  11. 11.6.1 Asia Amplicon Sequencing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Amplicon Sequencing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Amplicon Sequencing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Amplicon Sequencing Revenue (2021-2032)
  2. 12.2 SAMEA Amplicon Sequencing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Amplicon Sequencing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Amplicon Sequencing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Amplicon Sequencing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Amplicon Sequencing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Amplicon Sequencing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Amplicon Sequencing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Amplicon Sequencing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Amplicon Sequencing Revenue by Country
  11. 12.6.1 SAMEA Amplicon Sequencing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Amplicon Sequencing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Amplicon Sequencing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst